Related Experiment Video

Updated: May 26, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

[Intestinal dysbiosis in liver cirrhosis]

K V Zhdanov, D A Gusev, S M Zakharenko

    Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology
    |December 16, 2011
    PubMed

    Insights

    Intestinal dysbiosis affects 28.5% of liver cirrhosis patients, particularly those with advanced disease. This gut bacteria imbalance worsens the condition, especially in viral liver cirrhosis cases.

    Area of Science:

    • Gastroenterology and Hepatology
    • Microbiology
    • Clinical Medicine

    Context:

    • Liver cirrhosis is a significant global health issue.
    • Intestinal dysbiosis, an imbalance in gut microbiota, is increasingly recognized in chronic liver diseases.
    • The Child-Pugh score is a standard method for assessing cirrhosis severity.

    Purpose:

    • To investigate the prevalence of intestinal dysbiosis in liver cirrhosis patients.
    • To determine the association between intestinal dysbiosis and disease severity (Child-Pugh classes B and C).
    • To explore the impact of intestinal dysbiosis on the course of viral liver cirrhosis.

    Summary:

    • A hydrogen breath test revealed intestinal dysbiosis in 28.5% of liver cirrhosis patients.
    • Dysbiosis was more prevalent in patients classified as Child-Pugh B and C, indicating advanced disease.
    • Intestinal dysbiosis was found to aggravate the disease course in patients with viral liver cirrhosis.

    Impact:

    • Highlights the significant prevalence of intestinal dysbiosis in advanced liver cirrhosis.
    • Underscores the role of gut microbiota imbalance in disease progression and severity.
    • Suggests potential therapeutic targets for managing viral liver cirrhosis by addressing gut dysbiosis.

    Related Concept Videos

    Cirrhosis I: Introduction01:23

    Cirrhosis I: Introduction

    Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
    Cirrhosis II: Pathophysiology01:24

    Cirrhosis II: Pathophysiology

    Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
    Inflammatory Bowel Disease I: Ulcerative Colitis01:27

    Inflammatory Bowel Disease I: Ulcerative Colitis

    Introduction
    Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
    Risk Factors
    The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
    Chronic Bowel Disorders: Introduction01:17

    Chronic Bowel Disorders: Introduction

    Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
    Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
    Diseases of the Liver and Gallbladder01:26

    Diseases of the Liver and Gallbladder

    Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
    Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
    Inflammatory Bowel Disease II: Ulcerative Colitis01:20

    Inflammatory Bowel Disease II: Ulcerative Colitis

    Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...